Total Clarity Wealth Management, Inc. Cytosorbents Corp Transaction History

Total Clarity Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$4.05 - $8.11 $2,110 - $4,225	-521 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$7.0 - $9.71 $3,647 - $5,058	521 New	521 $4,000
Q2 2021 Jul 26, 2021	SELL	$7.55 - $9.42 $3,933 - $4,907	-521 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$8.23 - $11.48 $4,287 - $5,981	521 New	521 $5,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.